...
首页> 外文期刊>Obesity >Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study.
【24h】

Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study.

机译:非酒精性脂肪肝疾病的认知行为治疗:倾向评分调整的观察性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The effectiveness of cognitive-behavior treatment (CBT) in nonalcoholic fatty liver disease (NAFLD), largely related to overweight/obesity and considered the hepatic expression of the metabolic syndrome (MS), has so far been tested in very limited samples. In a tertiary referral center, consecutively observed NAFLD subjects were offered a CBT program aimed at weight loss and increased physical activity, based on 13 group sessions; 68 cases entered the treatment protocol, those who refused (n = 82) were given recommendations for diet and physical activity. Treatment goals (weight loss >/=7% initial body weight, normalization of liver enzymes, and improved parameters of MS) were tested by logistic regression at 6 months (all cases) and at 2 years, both on intention-to-treat and in completers (Diet, 78; CBT, 65). The results were adjusted for the propensity score of attending the CBT program, based on civil, anthropometric and clinical variables. At baseline the CBT group had a larger prevalence of obesity and more severe insulin resistance (homeostasis model assessment (HOMA)). At follow-up, CBT was associated with a higher probability of weight loss and normal liver enzymes (6-month: odds ratio (OR), 2.56; 95% confidence interval (CI), 1.15-5.69; 2-year intention-to-treat: OR, 3.57, 95% CI, 1.59-8.00), after adjustment for propensity and changes in body weight. A similar trend was observed in the outcome goals of insulin resistance and the score of MS, which were both reduced. In conclusion, subjects with NAFLD participating in a CBT program significantly improve their general and liver parameters. The beneficial effects are largely maintained at 2-year follow-up, in keeping with the lifestyle-related pathogenesis of disease.
机译:迄今为止,认知行为治疗(CBT)在非酒精性脂肪肝疾病(NAFLD)中的有效性主要与超重/肥胖有关,并且被认为是代谢综合征(MS)的肝脏表达,目前仅在非常有限的样本中进行了测试。在一个三级转诊中心,基于13个小组的课程,为连续观察的NAFLD受试者提供了旨在减轻体重和增加体育锻炼的CBT计划; 68例患者进入治疗方案,拒绝者(n = 82)被推荐饮食和体育锻炼。治疗目标(体重减轻> / = 7%初始体重,肝酶正常化和MS参数改善)在6个月(所有病例)和2年时通过logistic回归进行了意向治疗和治疗在完成者中(Diet,78; CBT,65)。根据公民,人体测量学和临床变量,对结果进行了调整,以适应参加CBT计划的倾向得分。基线时,CBT组的肥胖症患病率更高,胰岛素抵抗更为严重(体内稳态模型评估(HOMA))。在随访中,CBT与体重减轻和肝酶正常的可能性较高相关(6个月:优势比(OR)为2.56; 95%置信区间(CI)为1.15-5.69; 2年-治疗:OR,3.57,95%CI,1.59-8.00),针对倾向性和体重变化进行调整后。在胰岛素抵抗和MS评分的结局目标中观察到了相似的趋势,两者均降低了。总之,参与CBT计划的NAFLD受试者可显着改善其一般和肝脏参数。在2年的随访中,与生活方式相关的疾病发病机理基本保持了有益的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号